Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Rheumatology (Oxford, England)|December 23, 2021
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registriesDaniela Di Giuseppe, Ulf Lindström, Kalle Aaltonen, et al.Annals of the Rheumatic Diseases|February 22, 2023
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registriesBente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, et al.BMJ Open|May 11, 2023
Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis - study protocol for a randomised controlled trialSimon Jønck, Malte Lund Adamsen, Pil Højgaard, et al.Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.Annals of the Rheumatic Diseases|July 27, 2014
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryPil Højgaard, Bente Glintborg, Merete Lund Hetland, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 3, 2024
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized TrialRobin Christensen, Kristian Zobbe, Sabrina M Nielsen, et al.JACC. Basic to Translational Science|May 28, 2025
IL-6 Inhibitors and TNF Inhibitors: Impact on Exercise-induced Cardiac Adaptations in Patients With Rheumatoid ArthritisSimon Jønck, Malte Lund Adamsen, Iben E Rasmussen, et al.Seminars in Arthritis and Rheumatism|February 20, 2022
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registriesAlexander Egeberg, Nana Aviaaja Lippert Rosenø, David Aagaard, et al.RMD Open|April 24, 2018
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic exampleKaterina Chatzidionysiou, Merete Lund Hetland, Thomas Frisell, et al.Pageof 13